Supernus Pharmaceuticals, Inc. (SUPN)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.52B
Last updated: Nov 17, 2026 at 11:06 AM ET
Supernus Pharmaceuticals, Inc. (SUPN) Competitors
The companies most similar to Supernus Pharmaceuticals are Eton Pharmaceuticals (ETON), Amphastar (AMPH) and BioCryst Pharmaceuticals (BCRX). Supernus Pharmaceuticals trades at 12.7x earnings, against a median of 10.7x for the 11 of these companies with a P/E. By market cap, Supernus Pharmaceuticals ranks 7th of the 13 companies on this page; Bausch Health Companies (BHC) is the largest at $3.13B.
Peer Comparison
SUPN's revenue growth of 13.4% is above the peer median of 9.3%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Supernus Pharmaceuticals (SUPN) | $1.52B | 12.7x | 2.0x | 32.8% | N/A | 13.4% | 0.00% |
| Eton Pharmaceuticals Inc (ETON) | $1.84B | 36.7x | 13.0x | 35.3% | 37.0% | 157.9% | 0.00% |
| Amphastar P (AMPH) | $1.25B | 10.3x | 1.7x | 13.3% | 7.9% | 8.2% | 0.00% |
| BioCryst Pharmaceuticals Inc (BCRX) | $1.96B | 4.4x | 2.0x | -37.4% | 24937.1% | 13.1% | 0.00% |
| Pacira BioSciences, Inc. (PCRX) | $1.46B | 20.0x | 2.0x | 5.1% | 4.2% | -1.6% | 0.00% |
| Phibro Animal Health Corporation (PAHC) | $1.46B | 10.7x | 0.9x | 6.7% | 11.7% | 6.3% | 1.37% |
| Collegium Pharmaceutical Inc (COLL) | $786.83M | 3.7x | 1.0x | 4.7% | 8.1% | 3.3% | 0.00% |
| Prestige Brand Holdings Inc (PBH) | $2.19B | 10.7x | 2.0x | 13.3% | 5.0% | 22.7% | 0.00% |
| Cronos Group Inc (CRON) | $1.24B | 28.4x | 5.6x | 28.0% | N/A | 74.6% | 0.00% |
| Xeris Pharmaceuticals Inc (XERS) | $3.04B | 139.2x | 8.2x | -1.8% | 15.5% | 44.2% | 0.00% |
| Ironwood Pharmaceuticals Inc (IRWD) | $799.61M | 5.4x | 2.0x | 37.4% | 70.5% | 9.0% | 0.00% |
| Bausch Health Companies Inc (BHC) | $3.13B | 1.7x | 0.3x | -7.6% | 6.3% | 9.7% | 0.00% |
| HUTCHMED DRC (HCM) | $2.59B | N/A | 4.7x | 3.3% | -2.4% | 0.2% | 0.00% |
| Peer median | $1.65B | 10.7x | 2.0x | 5.9% | 8.1% | 9.3% | 0.00% |
Similar Companies
These are the 12 companies most similar to Supernus Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.
| Company | About | Peers |
|---|---|---|
| Eton Pharmaceuticals Inc (ETON) | Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. | ETON competitors |
| Amphastar P (AMPH) | Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation... | AMPH competitors |
| BioCryst Pharmaceuticals Inc (BCRX) | BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina. | BCRX competitors |
| Pacira BioSciences, Inc. (PCRX) | Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United... | PCRX competitors |
| Phibro Animal Health Corporation (PAHC) | Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily... | PAHC competitors |
| Collegium Pharmaceutical Inc (COLL) | Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. | COLL competitors |
| Prestige Brand Holdings Inc (PBH) | Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States... | PBH competitors |
| Cronos Group Inc (CRON) | Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada. | CRON competitors |
| Xeris Pharmaceuticals Inc (XERS) | Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. | XERS competitors |
| Ironwood Pharmaceuticals Inc (IRWD) | Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. | IRWD competitors |
| Bausch Health Companies Inc (BHC) | Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical... | BHC competitors |
| HUTCHMED DRC (HCM) | HUTCHMED (China) Limited discovers, develops and markets targeted immunotherapies and therapies for cancer and immune diseases globally. |
Frequently Asked Questions About SUPN
Who are Supernus Pharmaceuticals' main competitors?
The companies most similar to Supernus Pharmaceuticals include Eton Pharmaceuticals (ETON), Amphastar (AMPH), BioCryst Pharmaceuticals (BCRX), Pacira BioSciences (PCRX) and Phibro Animal Health (PAHC), listed from the closest match.
Who is Supernus Pharmaceuticals' biggest competitor?
Bausch Health Companies (BHC) is the largest of the similar companies at $3.13B; Eton Pharmaceuticals (ETON) is the closest match by business profile, size, sector and industry.
How does SUPN stock compare with its competitors?
SUPN's P/E is 12.7x against a peer median of 10.7x; its P/S is 2.0x against a peer median of 2.0x; its net margin is 32.8% against a peer median of 5.9%.
Which of Supernus Pharmaceuticals' competitors pays a higher dividend?
Supernus Pharmaceuticals pays no dividend. Phibro Animal Health (PAHC) has a higher forward dividend yield; Phibro Animal Health (PAHC) has the highest at 1.37%.
Is Supernus Pharmaceuticals bigger than its competitors?
No. Supernus Pharmaceuticals is 7th by market cap among the 13 companies on this page; the largest is Bausch Health Companies (BHC) at $3.13B.
SUPN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors